Gut microbiota DPP4-like enzymes are increased in type-2 diabetes and contribute to incretin inactivation.

Our findings confirm that proteolytic enzymes produced by the gut microbiota are likely to contribute to the glucose metabolic dysfunction that underlies T2D by inactivating incretins, which might inspire the development of improved antidiabetic therapies.